melatonin decreases olanzapine induced metabolic side-effects in adolescents with bipolar disorder: a randomized double-blind placebo-controlled trial.

نویسندگان

ali mostafavi psychiatric research center, roozbeh hospital, tehran university of medical sciences, tehran, iran.

mahmoud solhi psychiatric research center, roozbeh hospital, tehran university of medical sciences, tehran, iran.

mohammad-reza mohammadi psychiatric research center, roozbeh hospital, tehran university of medical sciences, tehran, iran.

mehdi hamedi psychiatric research center, roozbeh hospital, tehran university of medical sciences, tehran, iran.

چکیده

olanzapine is the frequently prescribed drug in children and adolescents with bipolar disorder, but unfortunately it has metabolic side-effects. on the other hand, in a number of melatonin studies on sleep cycle, regulation of metabolic abnormalities has been reported. therefore, we aimed to study effects of melatonin in reducing metabolic side-effects of olanzapine in 11-17 year-old patients with bipolar disorder. seventy-seven 11-17 year-old outpatients entered into the study after their initial diagnosis of bipolar mood disorder by a psychiatrist. after assessing inclusion and exclusion criteria, 48 patients consented to participate in the study. of this number, 24 patients were allocated to olanzapine, lithium carbonate, and melatonin and 24 patients were allocated to olanzapine, lithium carbonate, and placebo. young mania rating scale was performed at baseline. before treatment initiation and at sixth and twelfth weeks after treatment, lipid profile, fasting blood sugar (fbs), systolic blood pressure (sbp) and diastolic blood pressure (dbp) were measured. anova with repeated measure and independent sample t-test were used for data analysis. nineteen patients in each group completed the study and yielded data for analysis.  anova with repeated measure showed that fbs and triglyceride (tg) (especially in boys) demonstrated greater increase in the placebo group compared to the melatonin group but the differences were not statistically significant. melatonin significantly inhibited the rise in total cholesterol levels compared to placebo (p=0.032). mean sbp rose more slowly in the melatonin group (1.05mmhg) compared to placebo (6.36 mmhg) (p=0.023). the trends in dbp did not show any significant pattern. administration of melatonin along with olanzapine and lithium carbonate could significantly inhibit the rise in cholesterol level and sbp compared to placebo. the effect of melatonin on tg was more obvious in boys. melatonin was more effective in prevention of sbp rise.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Melatonin decreases olanzapine induced metabolic side-effects in adolescents with bipolar disorder: a randomized double-blind placebo-controlled trial.

Olanzapine is the frequently prescribed drug in children and adolescents with bipolar disorder, but unfortunately it has metabolic side-effects. On the other hand, in a number of melatonin studies on sleep cycle, regulation of metabolic abnormalities has been reported. Therefore, we aimed to study effects of melatonin in reducing metabolic side-effects of olanzapine in 11-17 year-old patients w...

متن کامل

Olanzapine/Fluoxetine combination in children and adolescents with bipolar I depression: a randomized, double-blind, placebo-controlled trial.

OBJECTIVE To assess the efficacy and safety of olanzapine/fluoxetine combination (OFC) for the acute treatment of bipolar depression in children and adolescents. METHOD Patients 10 to 17 years of age with bipolar I disorder (BP-I), depressed episode, baseline Children's Depression Rating Scale-Revised (CDRS-R) total score ≥40, Young Mania Rating Scale (YMRS) total score ≤15, and YMRS-item 1 ≤...

متن کامل

A Randomized, Double-Blind, Placebo-Controlled Trial of Citicoline for Cocaine Dependence in Bipolar I Disorder.

OBJECTIVE Although drug dependence is common in patients with bipolar disorder, minimal data are available on the treatment of drug dependence in this patient population. The authors previously reported a decreased risk of relapse to cocaine use in a pilot study of citicoline in patients with bipolar disorder and cocaine dependence. The primary aim of the present study was to determine whether ...

متن کامل

Maintenance N-acetyl cysteine treatment for bipolar disorder: A double-blind randomized placebo controlled trial

BACKGROUND N-acetyl cysteine (NAC) is a glutathione precursor that has been shown to have antidepressant efficacy in a placebo-controlled trial. The current study aimed to investigate the maintenance effects of NAC following eight weeks of open-label treatment for bipolar disorder. METHOD The efficacy of a double blind randomized placebo controlled trial of 2 g/day NAC as adjunct maintenance ...

متن کامل

A Randomized, Double-Blind, Placebo-Controlled Trial

Results: The cumulative number of gadoliniumenhancing MRI lesions during the first 6 months were similar in the -3 fatty acids and placebo groups (median difference, 1; 95% CI, 0 to 3; P=.09). No difference in relapse rate was detected after 6 (median difference, 0; 95% CI, 0 to 0; P=.54) or 24 (median difference, 0; 95% CI, 0 to 0; P=.72) months. The proportion of patients without disability p...

متن کامل

A Randomized, Placebo-Controlled Double-Blind Trial

The efficacy and safety of pentoxifylline were assessed in 297 adult patients with ischemic stroke in a molticenter, doable-blind, randomized and placebo-controlled trial. Treatment was started within 12 hoars after the stroke onset Study medication was administered intravenously continuously (16 mg/kg/day, maximum 1,200 mg/day) for 3 days and per os (400 mg ti.d.) for the remainder of 28 days....

متن کامل

منابع من

با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید


عنوان ژورنال:
acta medica iranica

جلد ۵۲، شماره ۱۰، صفحات ۷۳۴-۷۳۹

میزبانی شده توسط پلتفرم ابری doprax.com

copyright © 2015-2023